| 000 | 01420 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250515044217.0 | ||
| 264 | 0 | _c20071003 | |
| 008 | 200710s 0 0 eng d | ||
| 022 | _a0770-3198 | ||
| 024 | 7 |
_a10.1007/s10067-006-0454-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSimsek, Ismail | |
| 245 | 0 | 0 |
_aAtypical carcinoid tumor of the thymus with ectopic ACTH production developed during the course of etanercept treatment--case report. _h[electronic resource] |
| 260 |
_bClinical rheumatology _cSep 2007 |
||
| 300 |
_a1561-2 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadverse effects |
| 650 | 0 | 4 |
_aCarcinoid Tumor _xchemically induced |
| 650 | 0 | 4 | _aEtanercept |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin G _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPituitary ACTH Hypersecretion _xetiology |
| 650 | 0 | 4 | _aReceptors, Tumor Necrosis Factor |
| 650 | 0 | 4 |
_aSpondylarthritis _xdrug therapy |
| 650 | 0 | 4 |
_aThymus Neoplasms _xchemically induced |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aPay, Salih | |
| 700 | 1 | _aDinc, Ayhan | |
| 700 | 1 | _aErdem, Hakan | |
| 700 | 1 | _aKurt, Bulent | |
| 773 | 0 |
_tClinical rheumatology _gvol. 26 _gno. 9 _gp. 1561-2 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10067-006-0454-4 _zAvailable from publisher's website |
| 999 |
_c16636004 _d16636004 |
||